Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 676-680
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.676
Table 1 Changes in MAP and PVP during PVO, intraportal injection of microspheres and re-PVO after microsphere injections in experiment 1 (mean±SE).
BasalPVOMicrosphere injectionRe-PVO
MAP (kPa)
Group 111.6±0.413.0±0.3a8.8±0.4a9.0±0.4c
Group 211.2±0.313.2±0.5a8.5±0.3a9.3±0.3c
Group 311.4±0.412.6±0.3a11.5±3.912.4±0.3
PVP (kPa)
Group 14.1±0.313.0±0.3b4.5±0.3a8.4±0.3c
Group 24.5±0.213.2±0.4b5.1±0.2a9.2±0.2c
Group 34.2±0.212.6±0.3b4.2±0.212.4±0.3
Table 2 Changes in CVP, MAP, ABF and AR before and after intraportal injection of microspheres in experiment 2 (mean±SE).
Pre-injectionPost-injectionChange (%)
CVP (kPa)
Group 10.43±0.070.39±0.06-6.9±0.72
Group 20.40±0.080.38±0.59-5.5±0.66
Group 30.34±0.060.35±0.081.3±0.22
MAP (kPa)
Group 112.7±0.47.9±0.4a-38.1±1.9
Group 212.9±0.68.4±0.5a-35.4±2.1
Group 312.9±0.413.1±0.41.5±0.2
ABF (mL/min/ 100 g BW)
Group 14.2±0.33.4±0.3a-21.3±2.6
Group 23.7±0.23.1±0.2a-16.8±2.5
Group 34.1±0.34.2±0.32.1±0.1
AR (kPa/mL/ min/100 g BW)
Group 13.1±0.12.4±0.1a-21.0±2.3
Group 23.5±0.12.7±0.1a-21.7±2.3
Group 33.3±0.23.2±0.2-0.4±0.1
Table 3 Changes in MAP, ABF and AR following intraportal injection of microspheres (5.6×106) and infusion of Haemaccel (2 mL) via the jugular vein in group 5 of experiment 2.
BasalMicrosphere injectionHaemaccel injection
MAP (kPa)12.8±0.57.6±0.3b11.6±0.4ad
ABF (mL/min/ 100 g body weight)4.4±0.23.4±0.2b5.6±0.4bd
AR (kPa/mL/min/ 100 g body weight)2.9±0.12.3±0.1b2.1±0.1b